Board of Directors voted on Dec. 18 to adopt the 2026 regional transit operating budget and 2026-2030 capital program. After years of the agency and advocates ringing the alarm on a fiscal cliff when ...
Zacks Investment Research on MSN
GILD exercises option to license Assembly Bio's herpes programs
Gilead Sciences GILD recently announced that it has exercised its combined option to exclusively license Assembly Biosciences’ ASMB herpes simplex virus (HSV) helicase-primase inhibitor programs. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback